Sunday, March 04, 2018 6:05:33 PM
EXCITING BIOTECH STOCK NOW BREAKING OUT OF LARGE BASE...
Originally published Sunday, March 04, 2018
3D Signatures is an exciting Biotech company that now appears to be getting its act together fast, which is reflected in the recent action in its stock, although it is certainly not too late to buy the stock, otherwise we wouldn’t be interested in it. With respect to the fundamentals it is liked here by AlphaNorth Capital’s Steve Palmer for the reasons stated briefly in his recent article looking at 3 Small Caps that he favors.
We’ll now see what the charts have to say about it. On an 18-month log chart we can see all of the action in the stock since its inception, and the log chart has the advantage that it opens out the recent base pattern that has just completed, so that we can examine clearly what has been going on. As we can see, the severe decline through most of last year led into a fine large Head-and-Shoulders bottom formation that it started to break out of only a week ago. It didn’t hold a clear breakout and has dipped back to support at the upper boundary of the base pattern. This of course was partly due to the broad stockmarket diving, but as far as its chart is concerned it was due to a still challenging moving average alignment – we have yet to see a cross of the moving averages and the 200-day is still falling steeply – basically it needs a little more time, which is why it reacted back. Additional bullish points to observe on this chart are the high volume on the breakout move – the highest for about 10 months – which is bullish, the now climbing Accum-Distrib line, also positive and the improving momentum which has swung from negative to positive.
https://www.clivemaund.com/charts/dxd18month040318.jpg
The 3-month chart is valuable here as it enables us to see recent action in much more detail. Observe first the heavy volume when it broke out of the Head-and-Shoulders bottom about a week ago, which is bullish, and it is thanks to the broad market drop and still challenging moving average alignment, as mentioned above, that it has dropped back to what is considered to be a good entry point, given that we missed the opportunity to buy it near to the Right Shoulder low of the H&S pattern. Two factors that we can see to advantage on this chart which strongly suggest that it will turn higher from here are that it has reacted back to support at the January highs and the upper boundary of the entire base pattern, and also that volume has shrunk back to a very low level as it has reacted back, suggesting that there are few sellers at lower prices, because holders do not want to sell, for good reason. It could react back a little further but it is considered more likely that it will advance from here.
https://www.clivemaund.com/charts/dxd3month040318.jpg
Conclusion: 3D Signatures is viewed as a strong buy here for a resumption of its advance to complete its breakout from its large Head-and-Shoulders bottom pattern, which should usher in a major bullmarekt advance in this stock. The company’s stock trades in rather light volumes on the US OTC market, which are expected to improve as it advances.
3D Signatures website
3D Signatures Inc, DXD.V, TDSGF on OTC, closed at C$0.33, $0.252 on 2nd March 18.
Originally published Sunday, March 04, 2018
3D Signatures is an exciting Biotech company that now appears to be getting its act together fast, which is reflected in the recent action in its stock, although it is certainly not too late to buy the stock, otherwise we wouldn’t be interested in it. With respect to the fundamentals it is liked here by AlphaNorth Capital’s Steve Palmer for the reasons stated briefly in his recent article looking at 3 Small Caps that he favors.
We’ll now see what the charts have to say about it. On an 18-month log chart we can see all of the action in the stock since its inception, and the log chart has the advantage that it opens out the recent base pattern that has just completed, so that we can examine clearly what has been going on. As we can see, the severe decline through most of last year led into a fine large Head-and-Shoulders bottom formation that it started to break out of only a week ago. It didn’t hold a clear breakout and has dipped back to support at the upper boundary of the base pattern. This of course was partly due to the broad stockmarket diving, but as far as its chart is concerned it was due to a still challenging moving average alignment – we have yet to see a cross of the moving averages and the 200-day is still falling steeply – basically it needs a little more time, which is why it reacted back. Additional bullish points to observe on this chart are the high volume on the breakout move – the highest for about 10 months – which is bullish, the now climbing Accum-Distrib line, also positive and the improving momentum which has swung from negative to positive.
https://www.clivemaund.com/charts/dxd18month040318.jpg
The 3-month chart is valuable here as it enables us to see recent action in much more detail. Observe first the heavy volume when it broke out of the Head-and-Shoulders bottom about a week ago, which is bullish, and it is thanks to the broad market drop and still challenging moving average alignment, as mentioned above, that it has dropped back to what is considered to be a good entry point, given that we missed the opportunity to buy it near to the Right Shoulder low of the H&S pattern. Two factors that we can see to advantage on this chart which strongly suggest that it will turn higher from here are that it has reacted back to support at the January highs and the upper boundary of the entire base pattern, and also that volume has shrunk back to a very low level as it has reacted back, suggesting that there are few sellers at lower prices, because holders do not want to sell, for good reason. It could react back a little further but it is considered more likely that it will advance from here.
https://www.clivemaund.com/charts/dxd3month040318.jpg
Conclusion: 3D Signatures is viewed as a strong buy here for a resumption of its advance to complete its breakout from its large Head-and-Shoulders bottom pattern, which should usher in a major bullmarekt advance in this stock. The company’s stock trades in rather light volumes on the US OTC market, which are expected to improve as it advances.
3D Signatures website
3D Signatures Inc, DXD.V, TDSGF on OTC, closed at C$0.33, $0.252 on 2nd March 18.
Recent TDSGF News
- Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma • Newsfile • 04/14/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman • Newsfile • 03/31/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Price as Chief Financial Officer • Newsfile • 01/29/2026 01:00:00 PM
- Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program • Newsfile • 12/18/2025 09:05:00 PM
- Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting • Newsfile • 12/11/2025 09:00:00 PM
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 12/10/2025 02:57:30 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th • GlobeNewswire Inc. • 12/08/2025 01:35:00 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/05/2025 01:35:00 PM
- Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025 • Newsfile • 11/13/2025 01:30:00 PM
- American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition • Newsfile • 10/09/2025 12:30:00 PM
- Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update • Newsfile • 09/30/2025 08:30:00 PM
